(Q40859983)

24 September 2017

1 reference

title

The pharmacology of leishmaniasis (English)

1 reference

24 September 2017

1 reference

Balaña-Fouce R

1

1 reference

24 September 2017

Reguera RM

series ordinal

2

1 reference

24 September 2017

Cubría JC

series ordinal

3

1 reference

24 September 2017

Ordóñez D

series ordinal

4

1 reference

24 September 2017

1 April 1998

1 reference

24 September 2017

1 reference

24 September 2017

30

1 reference

24 September 2017

4

1 reference

24 September 2017

435-443

1 reference

Cutaneous leishmaniasis. Treatment with itraconazole

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Prevalence of Leishmania infection among AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Putrescine transport system in Leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Primary and secondary metabolism of pentamidine by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Effects of cationic diamidines on polyamine metabolism in the trypanosomatid Crithidia fasciculata

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Effects of cationic diamidines on polyamine content and uptake on Leishmania infantum in in vitro cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Leishmaniasis: some recent developments in chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Liposomal amphotericin B in drug-resistant visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Leishmaniasis. Public health aspects and control

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51 211 Janssen).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Topical chemotherapy of cutaneous Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Metabolism and functions of trypanothione in the Kinetoplastida

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Trypanothione is the primary target for arsenical drugs against African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Implications and concepts of polyamine-nucleic acid interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Ornithine decarboxylase of African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

American mucocutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Visceral leishmaniasis and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Liposomal amphotericin B, AmBisome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Kinetics and molecular characteristics of arginine transport by Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Allopurinol in the Treatment of American Cutaneous Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Treatment of recurrent cutaneous Leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Current treatment recommendations for leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Practical progress and new drugs for changing patterns of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Putrescine uptake inhibition by aromatic diamidines in leishmania infantum promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Influence of DNA-binding drugs on chromatin condensation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Polyamine depletion is associated with altered chromatin structure in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Comparison of Regimes of Treatment of Antimony-Resistant Kala-Azar Patients: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Therapy and prophylaxis of systemic protozoan infections

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900268-1

7 January 2021

10.1016/S0306-3623(97)00268-1

Identifiers

DOI

1 reference

24 September 2017

1 reference